logo

For the Inventor, By the Inventor

Ringoes, NJ, United States of America

Stanley Richard Krystek, Jr

This inventor holds 31 USPTO granted patents and 7 published patent applications, primarily in Monoclonal Antibodies. Top assignees: Bristol-Myers Squibb Compnay, Bristol Meyers Squibb Company. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stanley Richard Krystek, Jr. Retrieved from https://idiyas.com/inventor/stanley-richard-krystek-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 31 

% Patents Active = 87.1

Average Co-Inventor Count = 5.8

ph-index = 7

Forward Citations = 220(Granted Patents)


Company Filing History:

goldMedal30 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal1 out of 41 
 
Bristol Meyers Squibb Company
 patents

Years Active: 2003-2025

Loading Chart...
Areas of Expertise:
Antagonistic CD40
Monoclonal Antibodies
Fibronectin Proteins
Inflammatory Diseases
Factor XIa Inhibitors
IL-17A/F Antibodies
Glypican-3
Serum Albumin Binding
Selective Androgen Receptor Modulator
Metalloprotease
Polynucleotides
Bispecific Antibodies
31 patents (USPTO):Explore Patents
1. 12419953 - Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodies (2025-09-23),
2. 12409223 - Antagonistic CD40 monoclonal antibodies and uses thereof (2025-09-09),
3. 12065505 - Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof (2024-08-20),
4. 11926673 - Antagonistic CD40 monoclonal antibodies and uses thereof (2024-03-12),
5. 11813315 - Fibronectin based scaffold domain proteins that bind to myostatin (2023-11-14),
6. 11795231 - Antagonistic CD40 monoclonal antibodies and uses thereof (2023-10-24),
7. 11773178 - Antagonistic CD40 monoclonal antibodies and uses thereof (2023-10-03),
8. 11623965 - Prodruggable antibodies, prodrugs thereof, and methods of use and making (2023-04-11),
9. 11524992 - Glypican-3-binding fibronectin based scaffold molecules (2022-12-13),
10. 11512124 - Fibronectin type III domain proteins with enhanced solubility (2022-11-29),
11. 11434275 - Fast-off rate serum albumin binding fibronectin type III domains (2022-09-06),
12. 11261258 - Antagonistic CD40 monoclonal antibodies and uses thereof (2022-03-01),
13. 11254750 - Antagonistic CD40 monoclonal antibodies and uses in treating immune responses (2022-02-22),
14. 10787498 - Fibronectin type III domain proteins with enhanced solubility (2020-09-29),
15. 10766946 - Fast-off rate serum albumin binding fibronectin type III domains (2020-09-08),

Title: The Innovative Journey of Stanley Richard Krystek, Jr

Introduction: Stanley Richard Krystek, Jr, a talented inventor hailing from Ringoes, NJ (US), has made significant contributions to the world of technology and innovation.

Latest Patents: Stanley Richard Krystek, Jr holds several patents in various fields, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his illustrious career, Stanley Richard Krystek, Jr has been recognized for his groundbreaking inventions that have revolutionized industries and improved the lives of many.

Collaborations: Stanley Richard Krystek, Jr has collaborated with leading companies, research institutions, and universities to further develop and implement his innovative ideas, solidifying his reputation as a visionary inventor.

Conclusion: Stanley Richard Krystek, Jr's passion for innovation and his relentless pursuit of excellence continue to inspire future generations of inventors and shape the landscape of technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…